142 related articles for article (PubMed ID: 32026549)
1. Estimation of population-based utility weights for health states of chronic kidney disease, dialysis and kidney transplantation.
Jo MW; Lee HJ; Ryu DR; Park J; Ock M; Kim SH
Nephrology (Carlton); 2020 Jul; 25(7):544-550. PubMed ID: 32026549
[TBL] [Abstract][Full Text] [Related]
2. Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea.
Kim EJ; Ock M; Kim KP; Jung NH; Lee HJ; Kim SH; Jo MW
BMC Cancer; 2018 Nov; 18(1):1081. PubMed ID: 30409116
[TBL] [Abstract][Full Text] [Related]
3. Estimation of utility weights for major liver diseases according to disease severity in Korea.
Ock M; Lim SY; Lee HJ; Kim SH; Jo MW
BMC Gastroenterol; 2017 Sep; 17(1):103. PubMed ID: 28870162
[TBL] [Abstract][Full Text] [Related]
4. Estimation of utility weights for human papilloma virus-related health states according to disease severity.
Ock M; Park JY; Son WS; Lee HJ; Kim SH; Jo MW
Health Qual Life Outcomes; 2016 Nov; 14(1):163. PubMed ID: 27894347
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of chronic kidney disease in Korea using national sample cohort.
Kim SH; Jo MW; Go DS; Ryu DR; Park J
J Nephrol; 2017 Dec; 30(6):787-793. PubMed ID: 28303461
[TBL] [Abstract][Full Text] [Related]
6. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
[TBL] [Abstract][Full Text] [Related]
7. Estimation of Utility Weights for Prostate-related Health States in Korea.
Kim SH; Ock M; Jo MW; Park S
J Prev Med Public Health; 2022 May; 55(3):243-252. PubMed ID: 35677998
[TBL] [Abstract][Full Text] [Related]
8. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
9. Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.
Kim SH; Lee SI; Jo MW
Qual Life Res; 2017 Dec; 26(12):3387-3397. PubMed ID: 28801862
[TBL] [Abstract][Full Text] [Related]
10. Economic burden and cost-utility analysis of three renal replacement therapies in ESRD patients from Yunnan Province, China.
Wu H; Li Q; Cai Y; Zhang J; Cui W; Zhou Z
Int Urol Nephrol; 2020 Mar; 52(3):573-579. PubMed ID: 32009220
[TBL] [Abstract][Full Text] [Related]
11. Estimates of health utility scores in chronic kidney disease.
Sekercioglu N; Curtis B; Murphy S; Blackhouse G; Barrett B
Int Urol Nephrol; 2017 Nov; 49(11):2043-2049. PubMed ID: 28733768
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments.
Wyld M; Morton RL; Hayen A; Howard K; Webster AC
PLoS Med; 2012; 9(9):e1001307. PubMed ID: 22984353
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
[TBL] [Abstract][Full Text] [Related]
14. Estimating health state utilities in primary hyperoxaluria type 1: a valuation study.
de Freitas HM; Danese D; Hubig L; Lloyd A; Lombardelli S
J Med Econ; 2023; 26(1):386-393. PubMed ID: 36852648
[TBL] [Abstract][Full Text] [Related]
15. Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data.
van Oosten MJM; Logtenberg SJJ; Leegte MJH; Bilo HJG; Mohnen SM; Hakkaart-van Roijen L; Hemmelder MH; de Wit GA; Jager KJ; Stel VS
Nephrol Dial Transplant; 2020 Dec; 35(12):2138-2146. PubMed ID: 31598728
[TBL] [Abstract][Full Text] [Related]
16. Quality of life of young adults and adolescents with chronic kidney disease.
Tong A; Wong G; McTaggart S; Henning P; Mackie F; Carroll RP; Howard K; Craig JC
J Pediatr; 2013 Oct; 163(4):1179-85.e5. PubMed ID: 23800404
[TBL] [Abstract][Full Text] [Related]
17. Health and wealth in children and adolescents with chronic kidney disease (K-CAD study).
Wong G; Medway M; Didsbury M; Tong A; Turner R; Mackie F; McTaggart S; Walker A; White S; Howard K; Kim S; Craig JC
BMC Public Health; 2014 Apr; 14():307. PubMed ID: 24708535
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and estimates of utility in chronic kidney disease.
Gorodetskaya I; Zenios S; McCulloch CE; Bostrom A; Hsu CY; Bindman AB; Go AS; Chertow GM
Kidney Int; 2005 Dec; 68(6):2801-8. PubMed ID: 16316356
[TBL] [Abstract][Full Text] [Related]
19. Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review.
Cooper JT; Lloyd A; Sanchez JJG; Sörstadius E; Briggs A; McFarlane P
Health Qual Life Outcomes; 2020 Sep; 18(1):310. PubMed ID: 32957990
[TBL] [Abstract][Full Text] [Related]
20. Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial.
Knowles SR; Ski CF; Langham R; O'Flaherty E; Thompson DR; Rossell SL; Moore G; Hsueh YS; Castle DJ
Trials; 2016 Sep; 17(1):447. PubMed ID: 27612446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
